Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
06/2003
06/24/2003US6583136 Antifungal ethers
06/24/2003US6583090 Hetaryl-substituted benzyl phenyl ethers, method for the production thereof, and their use for combating harmful fungi and animal pests
06/24/2003CA2276405C Benzimidazole derivatives and pharmacologically acceptable salts thereof
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114496 Treatment or prevention of Alzheimer's disease
06/18/2003EP1319658A1 Imidazole derivatives or their salts
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318985A2 4-amino-quinazolines
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579871 Methods of using novel compounds as neuro-protective agents
06/12/2003WO2003048137A1 Metabotropic glutamate receptor-5 modulators
06/12/2003WO2003048078A2 Production of ionic liquids
06/12/2003WO2003047512A2 Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109521 Aryl substituted thiazolidinones and the use thereof
06/12/2003CA2468067A1 Metabotropic glutamate receptor-5 modulators
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045925A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003US20030105129 Chemical compounds
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/05/2003US20030105073 For therapy of cancer, inflammatory disorders, autoimmune disorders, psoriatic disorders and viral disorders
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP0967210B1 Process for preparing biologically active derivatives of 1,2,4-triazol and intermediaries useful in this process
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422257A Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
06/03/2003USRE38132 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
06/03/2003US6573293 Anticancer agents
05/2003
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043980A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/29/2003US20030100770 D-proline derivatives
05/29/2003US20030100765 Process for preparing heterocyclo-alkysulfonyl pyrazole derivatives
05/29/2003US20030100554 Pyrazole derivatives
05/28/2003EP1313725A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313712A2 Process and intermediates for preparing retroviral protease inhibitors
05/28/2003EP1155001A4 Isoquinoline derivatives and isoquinoline combinatorial libraries
05/28/2003CN1109674C Imidazole deriv. and process for preparing same
05/27/2003US6570037 Reacting a primary amine derivative containing another secondary or tertiary amine with a nitrobenzene containing carbonyl halide group
05/27/2003US6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
05/27/2003CA2066104C Benzazepine derivatives as vasopressin antagonists
05/22/2003WO2003042188A1 Triazole derivative and medicinal composition containing the same
05/22/2003WO2003022280A3 3-glyoxlylamideindoles for treating cancer
05/22/2003US20030096991 Reacting 2-sulfonamido, nitrobenzoic acid compound with in the presence of a halogenating agent, with formation of the carbonyl halide and its rearrangement; ammonolysis at SO2Cl group reducing at the nitro group; reacting with carbamate
05/22/2003US20030096846 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/22/2003US20030096836 2-Aroylimidazole compounds for treating cancer
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311471A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/21/2003EP0971709B1 Novel compounds useful as neuro-protective agents
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1109107C Chiral synthesis of tertiary alcohols with a hydrolase
05/21/2003CN1109021C Method of producing N,N'-diazole compounds
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566359 For use as platelet- activating factor antagonists, inhibitors of certain protein kinases, transcriptional inhibitors of COX-2(cyclooxygenase-2) expression, and as agents in protecting brain tissue from injuries related to trauma
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003WO2003039451A2 Thiazole pyridazinones as adenosine antagonists
05/15/2003US20030092751 3-glyoxlylamideindoles for treating cancer
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092709 6-Methylnicotinamide derivatives as antiviral agents
05/15/2003US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents
05/15/2003US20030092705 Reverse malaria drug resistance
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309561A1 1h-pyrazol derivatives, method for producing them and their use as nitrification inhibitors
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP0915869B1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/14/2003EP0773941B1 Tetrahydrofuran antifungals
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 163